IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,136.00
Bid: 12,134.00
Ask: 12,138.00
Change: 30.00 (0.25%)
Spread: 4.00 (0.033%)
Open: 12,166.00
High: 12,188.00
Low: 12,124.00
Prev. Close: 12,106.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 5-Europe enacts new curbs as COVID surges in absence of vaccine

Tue, 27th Oct 2020 10:57

(Adds Spain, EU)

* Anti-restriction protests turn violent in Italy

* France warns of "difficult decisions" ahead

* Trump pushes vaccines, but none yet available

By Crispian Balmer

ROME, Oct 27 (Reuters) - European governments moved on
Tuesday to impose new curbs to try to rein in a fast-growing
surge of coronavirus infections and provide economic balm to
help businesses survive the pandemic.

World leaders face an increasingly difficult task holding
the disease at bay while keeping their economies afloat as they
pin their hopes on as-yet unproven vaccines.

"We are dealing with exponential growth," German Economy
Minister Peter Altmaier told a virtual German-French economic
conference in Berlin. "In Germany the number of new infections
is rising by 70-75% compared to the week before."

The United States, Russia, France, Sweden, Poland and other
countries have registered record numbers of infections in recent
days as autumn turns to winter in the Northern Hemisphere and
people socialise indoors where the risk of infection is higher.

More than 43.4 million people have been infected by the
coronavirus globally and 1,158,056? have died, according to a
Reuters tally, with the United States leading the way in the
number of infections and deaths.

Hundreds of protesters took to the streets across Italy on
Monday to vent their anger at the latest round of restrictions,
including early closing for bars and restaurants, with
demonstrations in some cities turning violent.

In the financial capital Milan, youths hurled petrol bombs
at police, who responded with volleys of tear gas. In nearby
Turin, luxury shops had their windows smashed and some were
ransacked, leading to the arrest of 10 rioters.

In France, Interior Minister Gerald Darmanin warned the
country to prepare for "difficult decisions" after some of the
strictest restrictions currently in place anywhere in Europe
have failed to halt the spread of the disease.

The Czech government will ask lawmakers to extend its
emergency powers until Dec. 3, Prime Minister Andrej Babis said
on Tuesday, as it tries to stem one of the strongest surges in
infections in Europe.

BRAIN FUNCTION AFFECTED

There have been at least 8.54 million reported infections
and 251,000 deaths caused by coronavirus in Europe so far,
according to latest Reuters data. The continent registered a
record 230,892 new cases on Monday, up from 67,739 on Oct. 1.

Authorities in Russia, which with 1.55 million infections
has the world's fourth largest COVID-19 case load, ordered
people to wear facemasks in some public places and asked
regional authorities to consider shutting bars and restaurants
overnight.

New infections in Belgium, among the hardest-hit countries
in Europe, hit a high of more than 18,000 on Oct. 20, almost a
10-fold increase from the high of a spring wave of the pandemic.

The country is expected to decide by this weekend whether a
return to a nationwide lockdown is required.

Even Germany, widely praised for its initial response to the
pandemic, signalled concern on Tuesday over rising infections,
with Altmaier saying the country was likely to reach 20,000
cases a day by the end of this week.

Spain's wine-producing region of La Rioja ordered the
closure of restaurants and bars in its two largest towns for a
month. A nationwide curfew has been in place since Sunday.

A gauge of global stock markets fell and the U.S. dollar
slipped on Tuesday as investors grappled with a surge in
coronavirus cases and uncertainty over the impending U.S.
election.

Adding to the gloomy sentiment, a new study by Imperial
College London found that antibodies against the new coronavirus
declined rapidly in the British population during summer,
suggesting protection after infection may not be long-lasting.
Recovering patients may also suffer a decline in
brain function, researchers warned.

In the United States, the number of hospitalised COVID-19
patients is at a two-month high, straining health care systems
in some states. The U.S. death toll leads the world at more than
225,300.

"Until November 4th., Fake News Media is going full on
Covid, Covid, Covid," President Donald Trump, facing a tough
re-election battle on Nov. 3, tweeted on Tuesday in an
often-repeated refrain without offering evidence. "We are
rounding the turn. 99.9%."

Trump has often promoted vaccines as the answer, but none
has yet won international approval. Russia in August became the
first country to grant regulatory approval for a vaccine after
less than two months of human testing, raising eyebrows among
sceptical scientists in the West.

A vaccine being developed by the University of Oxford and
AstraZeneca Plc produces an immune response in both old
and young adults, the company said on Monday, raising hopes of a
path out of the gloom.

But only a share of the EU population can be inoculated
before 2022, should a vaccine become available, EU officials
said in an internal meeting on Tuesday.

The warning comes in spite of the fact that the 27-nation
bloc, with a population of 450 million, has secured more than a
billion doses of potential vaccines from three drugmakers.

(Reporting by Reuters bureaux; Writing by Crispian Balmer and
Nick Macfie; Editing by Alison Williams and Jon Boyle)

More News
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.